Pat Andrews

Public Company Board Member | Biotech Chief Executive Officer

Role
Board of Directors at Glenmark Pharmaceuticals
Location
Cambridge, MA, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Pat Andrews

Pat Andrews is a public company director and accomplished CEO with a history of transformative leadership in diverse pharmaceutical companies. A strategic executive with an especially broad functional background, Pat is an effective champion of biopharma companies with clinical stage compounds created from leading-edge science. She has launched successful products in the US and through partners in Europe and Asia, led and negotiated complex licensing and partnership agreements, and assembled and inspired high-performance teams around the world. A six-year Director and Member of the Audit Committee at GlycoMimetics (Nasdaq: GLYC), Pat has been a key voice on strategy, resource allocation, and funding decisions as the biotech navigates its first Phase trials, prepares for commercialization, and advances its early-stage portfolio.

Experience

  1. Board of Directors

    Glenmark Pharmaceuticals

    Aug 2025 — Present

Education

  • Brown University

    Bachelor of Arts - BA

  • University of Michigan

    Master of Business Administration - MBA

Skills

  • Management
  • Oncology
  • Biotechnology
  • Life Sciences
  • Sales Effectiveness
  • Managed Care
  • Strategic Planning
  • Lifesciences
  • Cross-Functional Team Leadership
  • Product Launch
  • Pharmaceutical Industry
  • Pharmaceutical Sales

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Pat Andrews — Board of Directors at Glenmark Pharmaceuticals in Cambridge, MA, US | Unifers